4//SEC Filing
STEINMETZ MICHAEL 4
Accession 0001209191-12-036059
CIK 0001339455other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 2:13 PM ET
Size
14.3 KB
Accession
0001209191-12-036059
Insider Transaction Report
Form 4
WHEELER KURT
Director
Transactions
- Sale
Common Stock
2012-06-28$0.29/sh−19,500$5,655→ 3,750,235 total(indirect: See Footnote)
GADICKE ANSBERT
10% Owner
Transactions
- Sale
Common Stock
2012-06-28$0.29/sh−19,500$5,655→ 3,750,235 total(indirect: See Footnote)
GALAKATOS NICHOLAS
10% Owner
Transactions
- Sale
Common Stock
2012-06-28$0.29/sh−19,500$5,655→ 3,750,235 total(indirect: See Footnote)
STEINMETZ MICHAEL
10% Owner
Transactions
- Sale
Common Stock
2012-06-28$0.29/sh−19,500$5,655→ 3,750,235 total(indirect: See Footnote)
EVNIN LUKE
10% Owner
Transactions
- Sale
Common Stock
2012-06-28$0.29/sh−19,500$5,655→ 3,750,235 total(indirect: See Footnote)
HENNER DENNIS
10% Owner
Transactions
- Sale
Common Stock
2012-06-28$0.29/sh−19,500$5,655→ 3,750,235 total(indirect: See Footnote)
SIMON NICHOLAS J III
10% Owner
Transactions
- Sale
Common Stock
2012-06-28$0.29/sh−19,500$5,655→ 3,750,235 total(indirect: See Footnote)
Footnotes (2)
- [F1]The shares were sold as follows: 16,255 by MPM BioVentures III-QP, L.P. ("BV III QP"), 1,093 by MPM BioVentures III, L.P. ("BV III"), 288 by MPM Asset Management Investors 2005 BVIII LLC ("AM 2005"), 491 by MPM BioVentures III Parallel Fund, L.P. ("BV Parallel") and 1,373 by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV KG"). MPM BioVentures III GP, L.P. ("MPM III GP") and MPM BioVentures III LLC ("MPM III LLC") are the direct and indirect general partners of BV III QP, BV III, BV Parallel and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Nicholas Simon III, Michael Steinmetz and Kurt Wheeler are the Series A members of MPM III LLC and the managers of AM 2005.
- [F2]The shares are held as follows: 3,126,063 by BV III QP, 210,200 by BV III, 55,377 by AM 2005, 94,429 by BV Parallel and 264,166 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
Documents
Issuer
Somaxon Pharmaceuticals, Inc.
CIK 0001339455
Entity typeother
Related Parties
1- filerCIK 0001166285
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 2:13 PM ET
- Size
- 14.3 KB